
Context Therapeutics Announces FDA Approval of ORSERDU
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) announced that its clinical trial collaborator, Stemline Therapeutics, Inc., a wholly-owned subsidiary of The Menarini Group, received approval from the U.S. Food …
Context Therapeutics Announces FDA Approval of ORSERDU Read More